Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DATAWATCH CORP
Report date December 13, 2018 · Filed December 13, 2018
Section 16 reporting ended · disclosed 2018-12-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-12-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-12-13 · Other · Disposed 41,833 · Balance 12,501 F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 5, 2018, by and among Datawatch Corporation, a Delaware corporation (the "Company"), Altair Engineering Inc., a Delaware corporation (the "Altair"), and Dallas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Altair (the "Purchaser"), and the terms of the Tender and Support Agreement, dated as of November 5, 2018, by and among Altair, Purchaser and each stockholder of the Company listed on Annex I of the Tender and Support Agreement, the reporting person disposed of these shares of the Company's Common Stock in the tender offer launched by Purchaser. Row 2 · 2018-12-13 · Disposition to issuer · Disposed 12,501 · Balance 0 F2: Pursuant to the terms of restricted stock unit ("RSU") grant agreements, the vesting of RSUs was accelerated in connection with the Merger and such RSUs became fully vested effective immediately prior to the effective time of the merger contemplated by the Merger Agreement (the "Merger"). Pursuant to the terms of the Merger Agreement, each such RSU was cancelled in the Merger and, in lieu of any issuance of shares in settlement of such RSU, converted into the right to receive a cash payment equal to $13.10 per share (without interest and less any applicable tax withholding). |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 5, 2018, by and among Datawatch Corporation, a Delaware corporation (the "Company"), Altair Engineering Inc., a Delaware corporation (the "Altair"), and Dallas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Altair (the "Purchaser"), and the terms of the Tender and Support Agreement, dated as of November 5, 2018, by and among Altair, Purchaser and each stockholder of the Company listed on Annex I of the Tender and Support Agreement, the reporting person disposed of these shares of the Company's Common Stock in the tender offer launched by Purchaser.
F2: Pursuant to the terms of restricted stock unit ("RSU") grant agreements, the vesting of RSUs was accelerated in connection with the Merger and such RSUs became fully vested effective immediately prior to the effective time of the merger contemplated by the Merger Agreement (the "Merger"). Pursuant to the terms of the Merger Agreement, each such RSU was cancelled in the Merger and, in lieu of any issuance of shares in settlement of such RSU, converted into the right to receive a cash payment equal to $13.10 per share (without interest and less any applicable tax withholding).
Merck & Co., Inc.
Report date June 09, 2004 · Filed June 09, 2004
Section 16 reporting ended · disclosed 2004-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 34,786 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 34,786 F1: No change since last filing. F2: The Reporting Person is no longer subject to Section 16 due to a corporate reorganization. |
| Deferred Stock Unit AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 39,200 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 39,200 F3: Not Applicable. F4: Granted under the Stock Incentive Plans. 27,200 of theses awards vest and are distributed in twenty-percent increments from 2005 to 2008, in accordance with the Plans. The remaining 12,000 vest and are 100% distributable on February 23, 2007. F5: Not Applicable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.13 · Expires 2008-02-22 | Direct | 31,200 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 31,200 F6: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.06 · Expires 2009-02-21 | Direct | 22,600 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 22,600 F6: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.75 · Expires 2010-02-21 | Direct | 22,600 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 22,600 F6: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.04 · Expires 2010-09-24 | Direct | 115,000 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 115,000 F7: Options were granted on September 25, 2000 and are exercisable in one-third increments on September 26 of each 2003, 2004 and 2005. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.05 · Expires 2011-02-25 | Direct | 34,500 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 34,500 F6: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.68 · Expires 2012-02-24 | Direct | 34,500 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 34,500 F6: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.85 · Expires 2013-02-23 | Direct | 24,600 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 24,600 F8: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.85 · Expires 2013-02-23 | Direct | 34,500 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 34,500 |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.20 · Expires 2014-02-22 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 50,000 F9: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 28,145.73 |
Reported balance
Holding disclosure · report date 2004-06-09 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 28,145.73 F10: 1 for 1 F11: Grant under the Long-Term Performance Share Unit Incentive Plan. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. F12: Includes 179.73 shares acquired pursuant to a dividend reinvestment feature of the Long-Term Performance Share Unit Incentive Plan, through May 26, 2004. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: No change since last filing.
F2: The Reporting Person is no longer subject to Section 16 due to a corporate reorganization.
F3: Not Applicable.
F4: Granted under the Stock Incentive Plans. 27,200 of theses awards vest and are distributed in twenty-percent increments from 2005 to 2008, in accordance with the Plans. The remaining 12,000 vest and are 100% distributable on February 23, 2007.
F5: Not Applicable.
F6: These options are currently exercisable.
F7: Options were granted on September 25, 2000 and are exercisable in one-third increments on September 26 of each 2003, 2004 and 2005.
F8: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006.
F9: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007.
F10: 1 for 1
F11: Grant under the Long-Term Performance Share Unit Incentive Plan. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer.
F12: Includes 179.73 shares acquired pursuant to a dividend reinvestment feature of the Long-Term Performance Share Unit Incentive Plan, through May 26, 2004. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2018 Filed Dec 13, 2018 17:16 UTC | DATAWATCH CORP DWCH · Entity 161801 | Disposition to issuerCommon Stock | 12,501 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-064487 · tv508875_4.xml · nonDerivative · entry 2 KELLY THOMAS H · CIK 0001023208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the terms of restricted stock unit ("RSU") grant agreements, the vesting of RSUs was accelerated in connection with the Merger and such RSUs became fully vested effective immediately prior to the effective time of the merger contemplated by the Merger Agreement (the "Merger"). Pursuant to the terms of the Merger Agreement, each such RSU was cancelled in the Merger and, in lieu of any issuance of shares in settlement of such RSU, converted into the right to receive a cash payment equal to $13.10 per share (without interest and less any applicable tax withholding). Read SEC document |
| December 13, 2018 Filed Dec 13, 2018 17:16 UTC | DATAWATCH CORP DWCH · Entity 161801 | OtherCommon Stock | 41,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-064487 · tv508875_4.xml · nonDerivative · entry 1 KELLY THOMAS H · CIK 0001023208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,501 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 5, 2018, by and among Datawatch Corporation, a Delaware corporation (the "Company"), Altair Engineering Inc., a Delaware corporation (the "Altair"), and Dallas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Altair (the "Purchaser"), and the terms of the Tender and Support Agreement, dated as of November 5, 2018, by and among Altair, Purchaser and each stockholder of the Company listed on Annex I of the Tender and Support Agreement, the reporting person disposed of these shares of the Company's Common Stock in the tender offer launched by Purchaser. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 17:00 UTC | DATAWATCH CORP DWCH · Entity 161801 | GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-021386 · tv491399_4.xml · nonDerivative · entry 1 KELLY THOMAS H · CIK 0001023208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,334 F1 · price: The securities awarded on 4/17/2018 are in the form of restricted stock units (RSUs) issued pursuant to the Datawatch Third Amended and Restated 2011 Equity Compensation and Incentive Plan. 2,333 RSUs will vest on 5/1/2019 and an additional 2,333 RSUs will vest on 5/1/2020, with the final 2,334 RSUs vesting on 5/1/2021. This vesting schedule is subject to acceleration in certain instances in connection with an acquisition or other change of control event. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 16:48 UTC | DATAWATCH CORP DWCH · Entity 161801 | GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-021294 · v464662_4.xml · nonDerivative · entry 1 KELLY THOMAS H · CIK 0001023208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,334 F1 · price: The securities awarded on 4/18/2017 are in the form of restricted stock units (RSUs) issued pursuant to the Datawatch Third Amended and Restated 2011 Equity Compensation and Incentive Plan. 2,333 RSUs will vest on 5/1/2018 and an additional 2,333 RSUs will vest on 5/1/2019, with the final 2,334 RSUs vesting on 5/1/2020. This vesting schedule is subject to acceleration in certain instances in connection with an acquisition or other change of control event. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantPhantom Stock Units · Derivative | 27,966 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000045 · kel367.xml · derivative · entry 3 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,966 Underlying: Common Shares · 27,966 shares Expires not disclosed F7 · derivative.exercise_price: 1 for 1 F9 · price: Not Applicable. F8 · derivative.exercise_date: Grant under the Long-Term Performance Share Unit Incentive Plan. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. F8 · derivative.expiration_date: Grant under the Long-Term Performance Share Unit Incentive Plan. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (Right to Buy) · Derivative | 50,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-04-000045 · kel367.xml · derivative · entry 2 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2014-02-22 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 12,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000045 · kel367.xml · derivative · entry 1 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 Underlying: Common Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on February 23, 2007. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 00:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 13,600 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-03-000141 · kel284.xml · derivative · entry 3 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,200 Underlying: Common Shares · 13,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 00:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 5,825 | $16.63 | $96,869.75 |
DisclosureSEC source: 0000310158-03-000141 · kel284.xml · nonDerivative · entry 2 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,786 Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 00:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 13,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-03-000141 · kel284.xml · nonDerivative · entry 1 KELLY THOMAS H · CIK 0001023208 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.